- Home
- HWH vs ADXN Comparison
HWH vs ADXN Comparison
Compare HWH & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HWH | ADXN |
|---|---|---|
| Founded | 2021 | 2002 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8M | 8.0M |
| IPO Year | 2022 | 2019 |
Fundamental Metrics
Financial Performance| Metric | HWH | ADXN |
|---|---|---|
| Price | $1.07 | $7.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 74.1K | 4.5K |
| Earning Date | 05-14-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.37 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $866,926.00 | N/A |
| Revenue This Year | N/A | $86.57 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.88 | $5.41 |
| 52 Week High | $7.77 | $12.05 |
Technical Indicators
Market Signals| Indicator | HWH | ADXN |
|---|---|---|
| Relative Strength Index (RSI) | 41.70 | 59.60 |
| Support Level | $0.88 | $7.22 |
| Resistance Level | $1.51 | $8.60 |
| Average True Range (ATR) | 0.17 | 0.64 |
| MACD | -0.01 | 0.16 |
| Stochastic Oscillator | 20.00 | 94.98 |
Price Performance
Historical ComparisonAbout HWH HWH International Inc.
HWH International Inc is and its consolidated subsidiaries operate a food and beverage business in Singapore and South Korea. The F&B business operates four cafes, two of which are located in South Korea and two in Singapore, as well as an online healthy food store, serving customers in Singapore.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.